H]-thymidine incorporation to ϳ 20-fold and retained 56% of their activity after incubation at 56 aeC, and 27% at 100 aeC, respectively. Neutralizing antibodies raised against platelet-derived growth factor (PDGF) partially suppressed the mitogenic potential of PRS. Gel exclusion chromatography analysis showed that molecules ranging from 25 kDa to more than 70 kDa within the PRS can stimulate BC proliferation. The highest amount of PDGF was detected in fractions corresponding to a molecular weight of 28-37 kDa as determined by immunoassay. The mitogenic activity was not restricted to soluble growth factors because microparticles in the PRS and platelet membranes also increased BC proliferation. Our data indicate that native platelets, the respective PRS, microparticles, and platelet membranes can stimulate the mitogenic activity of BC, thereby contributing to the regeneration of mineralized tissue.
Platelets are characteristically activated at sites of injury where they create a physical barrier to limit blood loss and accelerate the generation of thrombin to intensify the coagulation process.
8 Platelets can also release local mediators with phylogistic potential and interact with leukocytes and endothelial cells modulating the inflammatory reaction (Bazzoni et al. 1991; Klinger 1997) . In addition to haemostasis and inflammation, platelets are involved in wound healing and repair of mineralized tissue (Gentry 1992; Barnes et al. 1999) . As bone is a highly vascularized tissue, the biologic activities of platelets occur as immediate responses to fractures where the degranulation of platelets takes place during formation of a heamatoma. Vascular disruption also occurs in microfractures without any clinical sign of injury (Zuo & Zhu 1991) . Platelet-released growth factors are chemoattractant for mesenchymal cells of the external soft tissue and the bone marrow (Barnes et al. 1999) . Growth factors that are highly abundant in platelets can stimulate the proliferation and the dif-ferentiation of periosteal cells, and attract granulocytes and macrophages to the fracture haematoma (Joyce et al. 1990; Barnes et al. 1999) . Little is known regarding the interaction of platelets with cells of the osteogenic lineage.
Native platelets can be mitogenic for osteoblastic cells derived from fetal bone (Slater et al. 1995) . Two clinical studies have investigated the effects of platelets to reconstruct mandibular and vertebral defects (Marx et al. 1998; Lowery et al. 1999) ; the application of platelet-rich plasma results in a higher bone density within autologous bone grafts after 6months suggesting that endosteal osteoblasts that line the cancellous bone surface survive transplantation and are responsive to the platelet-released growth factors (Marx et al. 1998) . Among these growth factors, platelet-derived growth factor (PDGF) has been shown to stimulate bone cell replication (Hock & Canalis 1994; Yu et al. 1997) . PDGF increases bone matrix apposition and in vivo studies on tibial osteotomies in rabbits showed that exogenous PDGF has a stimulatory effect on fracture healing (Pfeilschifter et al. 1990; Nash et al. 1994) . Despite these results, it remains unclear whether PDGF is the only factor that mediates the interaction of platelets with BC.
Activation of platelets by physiologic agonists such as thrombin also results in the release of small (1mM) membrane vesicles from their surface, termed microparticles (MP) (Barry & FitzGerald 1999; Hughes et al. 2000) . Similar to growth factors, MP act in the local environment of their formation. MP have pro-as well as anticoagulant properties and their number is increased in the circulation of patients with syndromes of platelet activation (Barry & FitzGerald 1999) . Moreover, MP modulate the function of platelets, monocytes, and vascular endothelial cells, and stimulate the proliferation of coronary artery smooth muscle cells, independent of PDGF (Barry et al. 1998; Weber et al. 2000) . Given that the release of MP accompanies the vascular disruption at the fracture sites, we suggest that MP can have an effect on endosteal osteoblasts.
Here, we addressed the question whether native platelets and PRS can stimulate the proliferative activity of human trabecular BC. Our results show that platelets were genuinely highly mitogenic to BC, mediated, at least in part, by PDGF and MP, and 530 | Clin. Oral Impl. Res. 13, 2002 / 529-535 also that platelet membranes are involved in this process. These findings suggest a mechanism where platelets can contribute to the healing of skeletal defects and the regeneration of grafted bone matrix.
Material and methods

Human bone cells (BC)
Trabecular bone specimens were obtained from patients (62-88 years old) during routine hip replacements from the Department of Traumatology (Dr Mayer, Hospital Baden, Baden, Austria). Human trabecular BC were prepared as described by Evans and coworkers with minor modifications (Evans et al. 1990) . In brief, bone chips were extensively washed with PBS and placed in T-75 tissue-culture flasks (Costar, Cambridge, MA, USA) in the presence of DMEM/F12 (Life Technologies, Grand Island, NY, USA) supplemented with 10% fetal calf serum (Life Technologies), 100U/ml penicillin G, 100 mg/ml streptomycin, and 0.25 mg/ml amphotericin B (Life Technologies). This medium is termed serum-containing medium (SC-medium). Cells that grew out from the bone chips were cultured in a humidified atmosphere at 37aeC in 5% CO 2 for at least 2weeks. Medium was changed 3 times a week. Cells of the second and the third passage were used for experiments.
Isolation of platelet concentrates
Aphaeresis platelet concentrates from volunteer donors were prepared by standard aphaeresis procedures using an MCS π device (Haemonetics, Braintree, MA, USA) and acid citrate dextrose (ACD-A; 22g/l sodium citrate, 24.5g/l glucose monohydrate and 8g/l citric acid monohydrate; Haemonetics) as anticoagulant at a ratio of 1:10. The platelet concentrates were automatically leucodepleted by a negatively charged pall filter (LRF TM , XL), and fewer than 3¿10 3 white blood cells/ml remained in the platelet concentrates. The platelet concentrates were gently agitated at 21aeC on a platelet agitator (Helmer Laboratories, Nobesville, IN, USA) and aliquots were aseptically withdrawn after 3-4h.
Preparation of washed platelets, platelet supernatants, platelet membranes, and MP Platelets (3¿10 9 ) from platelet concentrates were washed in Tyrode's buffer, pH6.4, and centrifuged at 1400g for 10min
Pellets were resuspended in 3ml serumfree medium (SF-medium), which is a DMEM/F12 medium supplemented with 2.5mg/ml insulin-transferrin-selenium (Boehringer Mannheim, Germany) and antibiotics/antimycotics. The platelet suspension was diluted at a 1:5 ratio, resulting in platelet numbers of 2¿10 8 /ml (I); 4¿10 7 /ml (II); 8¿10 6 /ml (III); 1.6¿10 6 /ml (IV); and 3.2¿10 5 /ml (V). Release of platelet products into the supernatant was induced by adding 1U/ml of human thrombin (Sigma, St. Louis, MO, USA) to 1¿10 9 platelets/ml SF-medium for 20min at room temperature. After centrifugation at 1400g for 10 min, the PRS was diluted in the same way as described for experiments with washed platelets. PRS were also incubated for 5, 15, and 30min at 56aeC and 100aeC before dilution. Platelet membranes were prepared from resuspended pellets of thrombin-activated platelets after washing with PBS. MP were prepared as described by Weber et al. (2000) with minor modifications. In brief, 1ml of the platelet supernatant was further centrifuged at 100 000g for 1h at 4aeC. The particle-free supernatant was collected and the MP-pellet was resuspended in 1ml SF-medium. Both the MP and the corresponding particle-free PRS were diluted at the 1:5 ratio in SF-medium for analysis.
Mitogenic assay
The proliferation of human BC was measured by incorporation of radiolabeled [ 3 H]-thymidine (Amersham Pharmacia Biotech, Buckinghamshire, England) into the replicating strands of DNA produced during BC mitosis as recommended by the supplier of the gamma-counter with minor modifications (Topcount A , Packard, Meriden, CT, USA; http://www.packardbioscience.com/reference_matl/531.asp). In brief, BC were plated at 10000 cells/cm 2 in 96-well plates (Packard) and grown for 2-3days in SC-medium. The SC-medium was changed to SF-medium with and without the indicated concentrations (I-V, see above) of washed platelets, platelet membranes and supernatants for 24h. Cells were pulse-labeled with [ To determine the involvement of cell-tocell contact for the proliferative effect, human BC were grown in 24-well culture dishes (Costar) in the presence of various concentrations (I-V) of washed platelets for 24h, but separated by a membrane filter (Transwell, 6.5-mm diameter, 3.0-mm pore size, Costar). BC were pulsed with [ 3 H]-thymidine (3mCi/well) for the last 6h of culture. After removing unincorporated radioactivity, osteoblasts were released from the culture plate with 0.2% trypsin (Life Technologies) and harvested onto Unifilter-plates (Packard). Relative [ 3 H]-thymidine incorporation was determined by liquid scintillation counting.
Methanol/chloroform extraction of cellular lipids
Washed platelets (1¿10 9 /ml SF-medium) were lysed by sonification (Branson Sonifire 250; Schwäbisch Gmünd, Germany) for 2min at room temperature. Lipids were extracted according to a modified version of Bligh & Dyer (1959) . In brief, 1ml of disrupted platelets were incubated with 3.75ml chloroform/methanol (1:1, Merck, Darmstadt, Germany) for 10 min with continuous shaking. Thereafter, 1.25ml chloroform and 1.25ml H 2 O were added and after extensive vortexing, the tubes were centrifuged for 10min at 1400g. The lower phase containing the lipid fraction was evaporated and dissolved in 100ml ethanol. For analysis, 900 ml SF-medium was added to the lipid extract that was then diluted at the 1:5 ratio. The cell rem- nants within the interface were removed, washed two times with SF-medium, resuspended in 1ml of the same medium and diluted as described above.
Blocking of PDGF with an neutralizing antibody
Human BC were cultured with PRS corresponding to 8¿10 7 platelets/ml (Dilution II) in the presence of neutralizing antibodies raised against human PDGF (Clone AB-20-NA, R&D systems, MN, USA) for 24h and assayed for mitogenic activity. According to the information provided by the supplier, the half-maximal inhibition is 3-5mg antibody/ml for 10ng/ml natural human PDGF; hence, 1:100 dilutions can block 30ng PDGF/ml.
Gel exclusion chromatography of platelet supernatants and determination of PDGF
Chromatographic analysis was performed based on the handbook 'Gel Filtration, Principles and Methods' provided by the supplier of the equipment (Amersham Pharmacia). 800ml of PRS, corresponding to 1¿10 9 platelets/ml, was applied to a Sephadex G-75 column (1.6¿40 cm; Amersham Pharmacia Biotech) equilibrated with SF-medium and eluted at a flow rate of 50ml/h at room temperature. The column was calibrated using bovine serum albumin (67kDa), ovalbumin (43 kDa), chymotrypsinogen (25kDa) and ribonuclease A (12.7kDa). Fractions (1ml) were collected and assayed for their mitogenic activity and for their concentration of PDGF. PDGF was determined by a commercially avail- 
Results
Isolated platelets stimulate the proliferation of human BC
The effects of native platelets on BC proliferation were examined in a coculture model. BC cultured for 24h with SF-medium alone showed little mitogenic activity, whereas BC incubated with platelet suspensions resulted in a concentration-dependent increase of [ 3 H]-thymidine incorporation (Fig. 1) . Summarizing data from four experiments, 2¿10 8 platelets/ml (Dilution I) increased the mitogenic activity of BC 46∫15-fold when compared to SFmedium controls.
Cell-to-cell contact is not necessary for the effects of platelets on bone cell proliferation
We performed experiments where platelets were separated from BC by a 3.0-mm pore size filter to determine whether the biologic activity of platelets depends on the cell-to-cell contact. Similar to the cocul- Fig.2 . PRS increase the proliferation of human BC. Subconfluent human BC were cultured in 96-well plates, and incubated for 24h with and without the addition of PRS (black bars) and platelet membranes (white bars). The stock solutions were diluted corresponding to platelet numbers of 2¿10 ture experiments, the mitogenic activity of BC in response to platelets was increased in a dose-dependent mode of action up to 67∫15-fold, as indicated in Table1. The proliferative response observed in the coculture was not significantly different from experiments where platelets were separated by a membrane filter.
The lipid fraction of platelets does not stimulate the mitogenic activity of BC
The lipid fraction of the platelets was not mitogenic for BC, whereas the lipid-extracted cell remnants retained a mitogenic activity, shown by the dose-dependent increase in BC proliferation (Table2).
PRS enhance the proliferation of BC
Based on the observation that platelets can mediate their effects independently of cellto-cell contact, we investigated the proliferation of BC in response to PRS obtained from thrombin-stimulated cells. In these experiments, the addition of the PRS resulted in a dose-dependent stimulation of [ 3 H]-thymidine uptake into the DNA of BC when compared to unstimulated controls (Fig.2) . Summarizing four experiments, PRS corresponding to 2¿10 8 platelets/ml (Dilution I) increased the mitogenic activity of BC 20∫2-fold when compared to SFmedium controls. Supernatants from platelets that were either stimulated with ADP (2.5mM), serotonine (1mM), and collagen type I (0.1mg/ml) or disrupted by repeated freezing/thawing cycles also enhanced the Fig.3 . Preincubation of PRS at 56aeC and 100 aeC partially reduced their mitogenic potential. Subconfluent human BC were cultured in 96-well plates, and incubated for 24h with and without the addition of PRS. The supernatants were preincubated at 56aeC (black bars) and 100aeC (white bars) for the indicated time periods and diluted corresponding to platelet numbers of 2¿10 mitogenic activity of BC (data not shown). Platelet membranes that remain in the pellet after centrifugation were also mitogenic for BC, resulting in an 17∫7-fold increase in [ 3 H]-thymidine incorporation (Fig.2) .
The mitogenic activity of PRS decreased at higher temperatures
In order to characterize the heat sensitivity of the mitogenic components, PRS were preincubated at 56aeC and 100aeC before being added to BC. As shown in Fig. 3 , the incubation of the PRS at 100 aeC reduced the mitogenic activity to 27∫9% of unheated controls. The incubation of the PRS at 56aeC resulted in a time-dependent decrease of the rate of [ 3 H]-thymidine uptake into the DNA of BC, to 56∫1% after 30min. Additional experiments showed that the storage of the PRS at ª70aeC did not abrogate their mitogenic potential (data not shown).
Neutralization of PDGF decreased bone cell proliferation
Blocking experiments with a neutralizing antibody raised against human PDGF were performed to determine whether the mitogenic effects of the PRS were mediated by PDGF. In these experiments, the addition of the PDGF neutralizing antibody (at 1:100 dilution) blocked the stimulatory effect of supernatants corresponding to 4¿10 7 platelets/ml (Dilution II) between 23% and 56% (Fig.4) . Purified platelet-derived PDGF, which contains all the iso- forms that are naturally released from activated platelets (R&D systems), also increased the mitogenic activity of BC, although to a much lesser extent than PRS (data not shown).
Gel exclusion chromatography of PRS resulted in one major peak
We used G-75 gel filtration chromatography to correlate the molecular weight of molecules within the PRS with their mitogenic activity. The data show that plateletreleased molecules with a molecular weight higher than 25 kDa are mitogenic for BC, as shown in Fig.5 . PDGF could be detected in fractions corresponding to a molecular weight around 30 kDa (Table3). The addition of PDGF-neutralizing antibodies did not completely block the mitogenic activity of the 30kDa fraction (data not shown). Fractions corresponding to molecular weights higher than 68 kDa (Fractions 16-18) were also mitogenic for BC.
Platelet-derived MP stimulate the proliferation of BC
To examine whether platelet-derived MP, released upon stimulation with thrombin, are part of the mitogenic potential of PRS, BC were incubated with MP suspended in SF-medium, and with MP-free supernatants. Both MP and their respective supernatants enhanced the incorporation of [ 3 H]-thymidine by BC when compared to SF-medium controls. Preparations of MP Fig.5 . Sephadex G-75 gel chromatography of platelet supernatants showed a wide range of mitogenic activity. PRS corresponding to 1¿10 9 platelets/ml SFmedium, was applied to a Sephadex G-75 column (1¿40cm) and eluted at a flow rate of 50ml/h at room temperature. Fractions (1ml) were collected and assayed for their mitogenic activity. The calibration by bovine serum albumin (67kDa), ovalbumin (43kDa), chymotrypsinogen (25kDa) and ribonuclease A (13.7kDa) is indicated in the figure. Values are given as x-fold stimulation over untreated controls. Data are means ∫SD of results from quadruplicates. Fig.6 . MP and the corresponding particle-free supernatants stimulate the proliferation of BC. Human BC were incubated with platelet-released MP (white bars) and their respective particle-free supernatants (black bars) for 24 h in SF-medium. MP and the particle-free supernatants were obtained from PRS and diluted corresponding to platelet numbers of 2¿10 were less stimulatory than the MP-free supernatants. Summarizing four experiments, MP-suspensions corresponding to 2¿10 8 platelets/ml (Dilution I) increased the mitogenic activity of BC 6∫2.6 -fold, and MP-free supernatants 17∫7-fold, respectively (Fig.6) Supernatant of thrombin activated platelets. corresponding to 1 ¿ 10 9 platelets/ml SF-medium. was applied to a Sephadex G-75 column (1.6 ¿ 40 cm). Fractions (1 ml) were collected and assayed for their PDGF-concentration. Values are given in pg PDGF/ml. Data are means ∫ SEM.
after a fracture, during formation of the haematoma. It is suggested that platelet-released growth factors act locally at the site of injury, where they mediate the early events of fracture repair (Barnes et al. 1999) . Clinical studies have shown that the autologous application of platelets to bone grafts result in a higher bone density of the reconstructed mandibular defect (Marx et al. 1998) . Platelets are mitogenic for BC released from embryonic tissue, but no data exist with regard to cells of mature bone (Slater et al. 1995) .
Here we report that platelets strongly increased the proliferation of BC from adult individuals, supporting our hypothesis that platelets can act as local regulators of fracture repair and bone regeneration. A membrane filter that prevented cell-to-cell contact did not decrease the mitogenic effects, indicating the involvement of small platelet-released products. Based on observations by Ammon and coworkers that lipid extracts of platelets can stimulate the differentiation of monocytic cells, we investigated whether lipids may also account for the mitogenic activities on BC (Ammon et al. 1998) . In contrast to monocytic cells, lipid fractions of platelets did not stimulate [ 3 H]-thymidine uptake into BC.
These findings prompted us to analyze the supernatants of thrombin-activated platelets. PRS increased BC proliferation within a range corresponding to 2¿10 8 ª8¿10 6 platelets/ml, concentrations that reflect the physiologic number of platelets in the circulation. Purified thrombin can stimulate BC proliferation, although to a much lesser extent when compared to PRS (Frost et al. 1999) . The mitogenic activity of the PRS does not depend on thrombin-activation because similar results were obtained when platelets were treated either with ADP, serotonin, and collagen type I, or disrupted by repeated freezing/thawing (data not shown). It seems likely that thrombin can only partially contribute to the PRS-mediated [ 3 H]-thymidine uptake.
Native platelets were more potent stimulators for BC-proliferation than the respective PRS; these findings prompted us to determine whether platelet membranes that remain in the pellet after thrombinactivation can account for the different mitogenic activity. Resuspended platelet membranes increased BC proliferation, suggesting that the differences may be due to the mitogenic activity of platelet membranes and/or to growth factors that remained in the pellet after centrifugation.
We next investigated the heat sensitivity of PRS to get information about the thermostability of the molecules that cause the proliferative response. The data showed that PRS retained their mitogenic activity after incubation at 56aeC to 56%, vs. 27% at 100aeC, indicating that the increased [ 3 H]-thymidine incorporation into BC is mediated, at least in part, by heat stable growth factors.
PDGF is a heat stable molecule, highly abundant in platelets, that has been shown to increase the proliferation of osteoblastic cells, suggesting that it may account for the 'heat-insensitive' mitogenic effects of the supernatant (Strain et al. 1982; Hock & Canalis 1994) . Our data showed that the mitogenic effect of the PRS does not depend exclusively on the presence of PDGF because neither could the antibody against PDGF completely abolish the increase in DNA synthesis, nor could the PDGF-protein, purified from human platelets, reach the same mitogenic activity when compared to PRS. These observations indicate that PDGF is one of a larger number of platelet-released molecules with a mitogenic potential for BC (Kasperk et al. 1995) . The data are consistent with reports based on other in vitro models, showing that the effects of platelets are mediated by PDGF, but not exclusively.
In order to identify other components that may account for the observed mitogenic activity, PRS were size-fractionated by gel exclusion chromatography. The highest PDGF levels were detected in frac-tions corresponding to a molecular weight of ϳ30kDa. Blocking experiments showed that even in this particular fraction the mitogenic effect on BC could not be abolished by a PDGF-neutralizing antibody, indicating the presence of additional mitogenic growth factors with a similar molecular weight (Heldin et al. 1979; Heldin & Westermark 1999) . Moreover, fractions with a molecular weight higher than ϳ70 kDa also increased BC proliferation. The findings obtained by gel exclusion chromatography further suggest that PDGF is part of a larger number of mitogenic molecules that are released from activated platelets.
Published data and our own observations have led us to examine the effects of larger platelet-released products, the MP (Barry & FitzGerald 1999) . Indeed, MP increased [ 3 H]-thymidine incorporation into BC in a dose-dependent manner, though the MPfree supernatant was more potent in this regard. Based on the fact that MP are released from platelets in response to physiologic stimuli and enhance BC proliferation, it follows that, in addition to growth factors, MP may also contribute to the regeneration of mineralized tissue.
In summary, we have demonstrated that platelets stimulated the mitogenic activity of BC independent of cell-to-cell interaction, and that the proliferation rate of BC was increased in response to PRS, MP, and platelet membranes. These findings suggest that soluble factors and MP being released upon platelet activation, as well as platelet membranes can contribute to the regeneration of skeletal defects.
Résumé
Les plaquettes ont rendu la regeneration osseuse plus rapide dans les systémes de greffe. L'effet bénéfique des plaquettes pourrait comprendre leur halbilité à stimuler la proliferation des ostéoblastes. La response mitogénique des cellules derives de l'os trabéculaire humain sur les 
Resumen
Se ha implicado a las plaquetas en la regeneració n ó sea acelerada en aplicaciones de injerto. Los efectos beneficiosos de las plaquetas pueden incluir su habilidad para estimular la proliferació n de osteoblastos. Por lo tanto hemos determinado la respuesta mitogénica de las células derivadas del hueso trabecular humano a las plaquetas humanas y a los supernatants de las plaquetas activadas por trombina. Podemos mostrar un incremento de 50 veces en la síntesis de DNA de las células ó seas (BC) cultivadas en presencia de plaquetas tal como se determina por la incorporació n de [3H]-Timidina. El hecho de prevenir el contacto célula a célula por una membrana no abolió el efecto estimulador, indicando la liberació n de factor(es) solubles que con mitogénicos para (BC). La fracció n lipídica de las plaquetas no tuvo efecto sobre la toma de 
